Abstract
The aim was to investigate the insulin-releasing activity of motilin during and after feeding. A single intravenous bolus injection of motilin (0.01–0.3 μg/kg) dose-dependently stimulated endogenous release of insulin in the postprandial state. The insulin-releasing activity of motilin in the fed state was completely abolished by pretreatment with atropine or hexamethonium and was partly inhibited by ondansetron. Truncal vagotomy also greatly suppressed the motilin-induced insulin release. While phentolamine significantly enhanced insulin release in response to motilin, propranolol significantly inhibited this response in both states. The motilin-induced insulin release in the fed states was not accompanied by any changes in glucose concentrations. In conclusion, while the physiological significance remains unclear, these results indicate that physiological doses of motilin stimulate endogenous release of insulin via a vagally cholinergic muscarinic pathway, and that adrenergic and 5-hydroxytryptamine3 receptors are also involved in this response, in the dog.
Similar content being viewed by others
References
Unger RH, Eisentraut AM: Entero-insular axis. Arch Intern Med 123:261-266, 1969
Pederson RA, Browen JC: Interaction of gastric inhibitory polypeptide, glucose, and arginine on insulin and glucagon secretion from the perfused rat pancreas. Endocrinology 103:610-615, 1978
Suzuki H, Mochiki E, Haga N, Satoh M, Mizumoto A, Itoh Z: Motilin controls interdigestive cyclic release of insulin through vagal cholinergic muscarinic pathways in fasted dogs. Am J Physiol 274:G87-G95, 1998
Brown JC, Cook MA, Dryburgh JR: Motilin, a gastric motor activity stimulating polypeptide: The complete amino acid sequence. Can J Biochem 51:533-537, 1973
Buchan AM, Polak JM, Capella C, Solcia E, Pearse AG: Electronimmunocytochemical evidence for the K cell localization of gastric inhibitory polypeptide (GIP) in man. Histochemistry 56:37-44, 1978
Mori K, Seino Y, Itoh Z, Yanaihara N, Imura H: Motilin release by intravenous infusion of nutrients and somatostatin in conscious dogs. Reg Pept 1:265-270, 1981
Itoh Z, Takeuchi S, Aizawa I, Mori K, Taminato T, Seino Y, Imura H, Yanaihara N: Changes in plasma motilin concentration and gastrointestinal contractile activity in conscious dogs. Am J Dig Dis 23:929-935, 1978
Lee KY, Chey Wy, Tai HH, Yajima H: Radioimmunoassay of motilin: validation and studies on the relationship between plasma motilin and interdigestive myoelectric activity of the duodenum of dog. Am J Dig Dis 23:789-795, 1978
Itoh Z, Honda R, Hiwatashi K, Takeuchi S, Aizawa I, Takayanagi R, Couch EF: Motilin-induced mechanical activity in the canine alimentary tract. Scand J Gastroent 11 (Suppl 39):93-110, 1976
Lee KY, Chang TM, Chey WY: Effect of rabbit antimotilin serum on myoelectric activity and plasma motilin concentration in fasting dog. Am J Physiol 245:G547-G553, 1983
Itoh Z, Honda R, Takeuchi S, Aizawa I, Takayanagi R: An extraluminal force transducer for recording contractile activity of the gastrointestinal smooth muscle: Its construction and implantation. Gastroenterol Jpn 12:275-283, 1977
Shiba Y, Mizumoto A, Satoh M, Inui A, Itoh Z, Omura S: Effect of nonpeptide motilin agonist EM523 on release of gut and pancreatic hormones in conscious dogs. Gastroenterology 110:241-250, 1996
Flore M, Mitchell T, Doan R, Nelson R, Winter G, Grandone C, Zeng K, Harden R, Smith J, Harris K: The abbott IMxTM automated benchtop immunochemistry analyzer system. Clin Chem 34:1726-1732, 1988
Mochiki E, Satoh M, Tamura T, Haga N, Suzuki H, Mizumoto A, Sakai T, Itoh Z: Exogenous motilin stimulates endogenous release of motilin through cholinergic muscarinic pathways in the dog. Gastroenterology 111:1456-1464, 1996
Itoh Z, Takeuchi S, Aizawa I, Takayanagi R: Characteristic motor activity of the gastrointestinal tract in fasted conscious dogs measured by implanted force transducers. Am J Dig Dis 23:229-238, 1978
Szurszewski JH: A migrating electric complex of the canine small intestine. Am J Physiol 217:1757-1763, 1969
Perley MJ, Kipnis DM: Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects. J Clin Invest 46:1954-1962, 1967
McIntyre N, Holdsworth CD, Turner DS: New interpretation of oral glucose tolerance. Lancet 2:20-21, 1964
Elrick H, Stimmer L, Hlad CJ, Arai Y: Plasma insulin response to oral and intravenous glucose tolerance. J Clin Endocrinol 24:1076-1082, 1964
Goldberg NJ, Wingert TD, Levin SR, Adachi RI: Augmentation of insulin secretion by a non-nutrient drink. Gastroenterology 78:1458-1462, 1980
Creutzfeldt W: The incretin concept today. Diabetologia 16:75-85, 1979
Rabinovitch A, Dupre J: Effects of the gastric inhibitory polypeptide present in impure pancreozymin-cholecystokinin on plasma insulin and glucagon in the rat. Endocrinology 94:1139-1144, 1974
Dupre J, Ross SA, Watson D, Brown JC: Stimulation of insulin secretion by gastric inhibitory polypeptide in man. J Clin Endocrionl Metab 37:826-828, 1973
Sarson DL, Wood SM, Kansal PC, Bloom SR: Glucose-dependent insulinotropic polypeptide augmentation of insulin. Physiology or pharmacology? Diabetes 33:389-393, 1984
Ebert R, Illmer K, Creutzfeldt W: Release of gastric inhibitory polypeptide (GIP) by intraduodenal acidification in rats and humans and abolishment of the incretin effect of acid by GIP-antiserum in rats. Gastroenterology 76:515-523, 1979
Schwartz TW, Holst JJ, Fahrenkrug J, Jensen SL, Nielsen OV, Rehfeld JF, Schaffalitzky de Muckadell OB, Stadil F: Vagal, cholinergic regulation of pancreatic polypeptide secretion. J Clin Invest 61:781-789, 1978
Frohman LA, Ezdinli EZ, Javid R: Effect of vagotomy and vagal stimulation on insulin secretion. Diabetes 16:443-448, 1967
Schwartz TW: Pancreatic polypeptide: A hormone under vagal control. Gastroenterology 85:1411-1425, 1983
Ahren B, Taborsky GJ: The mechanism of vagal nerve stimulation of glucagon and insulin secretion in the dog. Endocrinology 118:1551-1557, 1986
Berthoud H-R, Fox WA, Powley TL: Localization of vagal preganglionics that stimulate insulin and glucagon secretion. Am J Physiol 258:R160-R168, 1990
Stagner JI, Samols E: Role of intrapancreatic ganglia in regulation of periodic insular secretions. Am J Physiol 248:E522-E530, 1985
Larsson LI, Rehfeld JF: Peptidergic and adrenergic innervation of pancreatic ganglia. Scand J Gastroenterol 14:433-437, 1979
Miller RE: Pancreatic neuroendocrinology: Peripheral neural mechanisms in the regulation of the islets of Langerhans. Endocr Rev 2:471-494, 1981
Malaisse W, Malaisse-Lagae F, Wright PH, Ashmore J: Effects of adrenergic and cholinergic agents upon insulin secretion in vitro. Endocrinology 80:975-978, 1967
Kaneto A, Sato H, Kaneko T, Yanaihara C, Yanaihara N, Kosaka K: Stimulation of somatostatin, pancreatic polypeptide, glucagon and insulin secretion by acetylcholine infused intrapancreatically in dogs. Biomed Res 2:57-66, 1981
Mochiki E, Inui A, Satoh M, Mizumoto A, Itoh Z: Motilin is a biosignal controlling the cyclic release of pancreatic polypeptide via the vagus in fasted dogs. Am J Physiol 272:G224-G232, 1997
Iversen J: Adrenergic receptors and the secretion of glucagon and insulin from the isolated, perfused canine pancreas. J Clin Invest 52:2102-2116, 1973
Itoh Z, Takahashi I: Periodic contractions of the canine gallbladder during the interdigestive state. Am J Physiol 240:G183-G189, 1981
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Suzuki, H., Kuwano, H., Mochiki, E. et al. Effect of Motilin on Endogenous Release of Insulin in Conscious Dogs in the Fed State. Dig Dis Sci 48, 2263–2270 (2003). https://doi.org/10.1023/B:DDAS.0000007861.91075.b3
Issue Date:
DOI: https://doi.org/10.1023/B:DDAS.0000007861.91075.b3